SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 5,283.35 |
| Enterprise Value ($M) | 7,875.64 |
| Book Value ($M) | 606.77 |
| Book Value / Share | 1.60 |
| Price / Book | 8.71 |
| NCAV ($M) | 361.61 |
| NCAV / Share | 0.96 |
| Price / NCAV | 14.61 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.04 |
| Return on Assets (ROA) | -0.02 |
| Return on Equity (ROE) | -0.04 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.26 |
| Current Ratio | 1.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,823.51 |
| Assets | 2,068.67 |
| Liabilities | 1,461.90 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 388.97 |
| Operating Income | -14.02 |
| Net Income | -22.69 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 185.22 |
| Cash from Investing | -2.41 |
| Cash from Financing | 40.35 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,549,850 | 7,518,894 | 33.91 | |
| 4,238,345 | 10,974,208 | 38.62 | |
| 2,965,135 | 8,904,709 | 33.30 | |
| 3,960,201 | 12,540,743 | 31.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BOLT – Bolt Biotherapeutics, Inc. | BON – Bon Natural Life Limited |
| BTAI – BioXcel Therapeutics, Inc. | BYSI – BeyondSpring Inc. |
| CALC – CalciMedica, Inc. |
Financial data and stock pages provided by
Fintel.io